Tag:
ActoGenix
Latest Headlines
Latest Headlines
Early dialogue with regulators key in global trials
Given the complexities of reporting to multiple regulators in global clinical trials, study design needs to be driven by the information required to get the project to the next step with the minimum
ActoGeniX garners $17M in second round
Belgium's ActoGenix has returned to the venture capital well for $17 million in fresh funds. The fledgling developer is a spin-off of VIB and Ghent University. And it says it expects to see a
